NDC 0078-1021

VIJOICE

Alpelisib

VIJOICE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Alpelisib.

• Product ID: 0078-1021_0cb830fe-2016-49d1-a5d6-e61fe3faffd2
• NDC: 0078-1021
• Product Type: Human Prescription Drug
• Proprietary Name: VIJOICE
• Generic Name: Alpelisib
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2022-04-05
• Marketing Category: NDA /
• Application Number: NDA215039
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: ALPELISIB
• Active Ingredient Strength: 50 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-1021-84

1 BLISTER PACK in 1 CARTON (0078-1021-84) > 28 TABLET in 1 BLISTER PACK (0078-1021-51)

• Marketing Start Date: 2022-04-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "VIJOICE" or generic name "Alpelisib"

NDC	Brand Name	Generic Name
0078-1021	VIJOICE	alpelisib
0078-1028	VIJOICE	alpelisib
0078-1035	VIJOICE	alpelisib
0078-0701	PIQRAY	alpelisib
0078-0708	PIQRAY	alpelisib
0078-0715	PIQRAY	alpelisib